ARCHIVES

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

Conversation with The Cancer Letter: Is Republican Control Better Than Two-Party Stalemate?

December 19, 2014

ASCO Letter To NCI Urges Increased Support for Clinical Trials, Training, Translational Research

March 6, 2009

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

September 25, 1998

National Dialogue On Cancer, The Cancer Act, And Activism.

February 4, 2000

QOL With Femara Comparable To Placebo, Analysis Finds

December 26, 2003

NCI Cancer Education Program To Open To Innovative Ideas

April 2, 1993